Aveanna Healthcare Holdings Inc.AVAHNASDAQ
Loading

Latest News

Aveanna Healthcare (AVAH) to Release Quarterly Earnings on Thursday
defenseworld.net

Aveanna Healthcare (AVAH) to Release Quarterly Earnings on Thursday

Aveanna Healthcare (NASDAQ: AVAH - Get Free Report) is projected to issue its Q4 2025 results before the market opens on Thursday, March 12th. Analysts expect the company to announce earnings of $0.13 per share for the quarter. Investors may review the information on the company's upcoming Q4 2025 earning report for the latest details on

Aveanna's Heartways Program Receives CHAP Disease Program Certification
globenewswire.com

Aveanna's Heartways Program Receives CHAP Disease Program Certification

ATLANTA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Community Health Accreditation Partner (CHAP), an independent, non-profit accrediting body for home and community-based healthcare, and Aveanna Healthcare (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care in the home, announced today that Aveanna Home Health and Hospice, a division of Aveanna Healthcare, has been awarded a Disease Program Certification for Heart Failure under the CHAP Disease Program Standards. CHAP certification demonstrates that Aveanna Home Health and Hospice meets the industry's highest nationally recognized standards.

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Given Consensus Recommendation of “Hold” by Brokerages
defenseworld.net

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Given Consensus Recommendation of “Hold” by Brokerages

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH - Get Free Report) has received a consensus rating of "Hold" from the eleven research firms that are currently covering the stock, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month target

Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance
globenewswire.com

Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance

ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced updated full year guidance for fiscal year 2025 (year ended January 3, 2026) and its initial full year guidance for fiscal year 2026 (year ending January 2, 2027).

Financial Review: Aveanna Healthcare (NASDAQ:AVAH) versus Elanco Animal Health (NYSE:ELAN)
defenseworld.net

Financial Review: Aveanna Healthcare (NASDAQ:AVAH) versus Elanco Animal Health (NYSE:ELAN)

Aveanna Healthcare (NASDAQ: AVAH - Get Free Report) and Elanco Animal Health (NYSE: ELAN - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership. Analyst Ratings This is a breakdown of

Matthew Buckhalter Sells 17,289 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock
defenseworld.net

Matthew Buckhalter Sells 17,289 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH - Get Free Report) CFO Matthew Buckhalter sold 17,289 shares of Aveanna Healthcare stock in a transaction dated Wednesday, December 31st. The shares were sold at an average price of $8.18, for a total transaction of $141,424.02. Following the completion of the sale, the chief financial officer directly owned 455,320

Edwin Reisz Sells 17,613 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock
defenseworld.net

Edwin Reisz Sells 17,613 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH - Get Free Report) insider Edwin Reisz sold 17,613 shares of the stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $7.85, for a total value of $138,262.05. Following the completion of the transaction, the insider owned 1,321,114 shares in